NASDAQ:DICE
DICE Therapeutics, Inc.
- Stock
Last Close
47.52
08/08 20:00
Market Cap
2.27B
Beta: -
Volume Today
4.33M
Avg: 534.33K
PE Ratio
−23.17
PFCF: −26.04
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | |||||
average payables | 3.05M - | 3.40M 11.56% | 2.39M 29.59% | ||
average receivables | 2M - | 2M 0% | 1M 50% | ||
book value per share | -1.28 - | -2.29 79.40% | -8.37 265.97% | -4.76 43.15% | |
capex per share | -0.04 - | -0.01 84.91% | -0.06 809.84% | -0.06 2.07% | |
capex to depreciation | -1.39 - | -0.21 84.72% | -1.09 411.56% | -0.92 15.01% | |
capex to operating cash flow | 0.06 - | 0.01 88.11% | 0.02 155.32% | 0.03 90.32% | |
capex to revenue | -0.17 - | -0.17 0.96% | -0.64 272.15% | ||
cash per share | 1.15 - | 2.57 124.16% | 25.78 903.34% | 14.57 43.48% | |
days of inventory on hand | |||||
days payables outstanding | |||||
days sales outstanding | 126.41 - | 845.89 569.18% | 648.89 23.29% | ||
debt to assets | 0.01 - | 0.00 78.45% | 0.01 379.30% | 0.02 203.63% | |
debt to equity | -0.01 - | -0.00 75.39% | -0.02 1,152.90% | -0.07 206.06% | |
dividend yield | |||||
earnings yield | -0.02 - | -0.03 83.22% | -0.15 457.84% | -0.07 57.04% | |
enterprise value | 848.54M - | 797.19M 6.05% | 200.01M 74.91% | 781.19M 290.57% | |
enterprise value over ebitda | -69.52 - | -34.83 49.89% | -4.21 87.90% | -9.41 123.34% | |
ev to operating cash flow | -52.06 - | -38.55 25.95% | -5.09 86.80% | -12.14 138.59% | |
ev to sales | 146.93 - | 923.75 528.69% | 177.79 80.75% | ||
free cash flow per share | -0.74 - | -0.90 20.53% | -3.23 260.28% | -1.69 47.71% | |
free cash flow yield | -0.02 - | -0.02 20.53% | -0.13 425.12% | -0.05 57.58% | |
graham net net | -1.41 - | -2.40 70.82% | 24.87 1,134.88% | 13.89 44.16% | |
graham number | 4.00 - | 7.26 81.30% | 27.16 274.26% | 14.90 45.13% | |
income quality | 1.26 - | 0.87 30.85% | 0.80 7.87% | 0.77 4.46% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -521.04 - | -1.82K 250.20% | -273.58 85.01% | -129.93 52.51% | |
interest debt per share | 0.01 - | 0.00 55.24% | 0.21 4,242.21% | 0.35 70.53% | |
inventory turnover | |||||
invested capital | -0.01 - | -0.00 75.39% | -0.02 1,152.90% | -0.07 206.06% | |
market cap | 856.78M - | 856.78M 0% | 313.44M 63.42% | 1.23B 292.20% | |
net current asset value | -31.71M - | -54.95M 73.30% | 311.11M 666.11% | 550.77M 77.04% | |
net debt to ebitda | 0.68 - | 2.60 285.43% | 2.39 8.23% | 5.40 125.92% | |
net income per share | -0.56 - | -1.02 83.22% | -3.91 282.73% | -2.07 47.05% | |
operating cash flow per share | -0.70 - | -0.89 26.88% | -3.17 256.35% | -1.63 48.55% | |
payables turnover | |||||
receivables turnover | 2.89 - | 0.43 85.06% | 0.56 30.36% | ||
research and ddevelopement to revenue | 2.72 - | 22.69 733.76% | 32.45 43.02% | ||
return on tangible assets | -0.42 - | -0.37 10.54% | -0.15 59.99% | -0.14 7.60% | |
revenue per share | 0.25 - | 0.04 85.06% | 0.09 144.48% | ||
roe | 0.44 - | 0.45 2.12% | 0.47 4.58% | 0.44 6.86% | |
roic | 0.47 - | 0.45 3.65% | 0.47 3.78% | 0.53 14.62% | |
sales general and administrative to revenue | 0.62 - | 5.80 828.35% | 10.86 87.36% | ||
shareholders equity per share | -1.28 - | -2.29 79.40% | -8.37 265.97% | -4.76 43.15% | |
stock based compensation to revenue | 0.09 - | 0.64 603.33% | 4.96 670.01% | ||
tangible asset value | -29.62M - | -53.15M 79.40% | 312.95M 688.86% | 566.99M 81.18% | |
tangible book value per share | -1.28 - | -2.29 79.40% | 25.27 1,204.36% | 14.39 43.06% | |
working capital | 25.39M - | 52.76M 107.84% | 313.03M 493.30% | 562.61M 79.73% |
All numbers in USD (except ratios and percentages)